Home/Filings/4/0001209191-09-018314
4//SEC Filing

ANDRZEJEWSKI STEPHEN J 4

Accession 0001209191-09-018314

CIK 0001047699other

Filed

Mar 24, 8:00 PM ET

Accepted

Mar 25, 5:20 PM ET

Size

7.4 KB

Accession

0001209191-09-018314

Insider Transaction Report

Form 4
Period: 2009-03-23
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2009-03-23+15,690150,122 total
  • Award

    Stock Option (Right to Buy)

    2009-03-23+49,54049,540 total
    Exercise: $6.97Exp: 2019-03-23Common Stock (49,540 underlying)
Footnotes (2)
  • [F1]Represents restricted stock that was issued on March 23, 2009. One hundred percent of such stock vests on March 23, 2012.
  • [F2]33% of the option vests on March 23, 2010; 33% of the option vests on March 23, 2011; and 34% of the option vests on March 23, 2012.

Issuer

KING PHARMACEUTICALS INC

CIK 0001047699

Entity typeother

Related Parties

1
  • filerCIK 0001321648

Filing Metadata

Form type
4
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:20 PM ET
Size
7.4 KB